Board Changes

Surgical Innovations Group PLC

28 September 2026

 

Surgical Innovations Group plc

(“Surgical Innovations”, the “Company”, or the “Group”)

 

Board Changes

Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and distributor of innovative medical technology for minimally invasive surgery (“MIS”), announces the following Board changes:

After 9 years in executive roles at Surgical Innovations, David Marsh has decided to step down from his role as Chief Executive Officer (“CEO”) and will transition to the role of Non-Executive Director of the Company on 1 October 2026. As part of this transition, David will continue to support the new CEO, including through key relationships and business development opportunities. David joined the Group following Surgical Innovations’ acquisition of Elemental Healthcare, the company he jointly founded.

Alex Warnock will join the Board of the Company as CEO on the same date. Alex is a commercially driven public company board director with over 25 years’ experience in senior operational roles. Alex brings extensive international experience driving transformational growth and shareholder value across high-tech manufacturing, Photonics and regulated MedTech sectors. He was previously Group Managing Director of SDI Group plc and before that Chief Operating Officer at Foster & Freeman Ltd, Gooch & Housego plc, and Optos plc. He has a proven track record in delivering profitable revenue growth and operational excellence, developing new products, and commercialising complex clinical technologies with an entrepreneurial, hands-on approach to scaling innovative smaller enterprises and navigating highly regulated global markets.

Commenting on the Board changes, Roy Davis, Chairman of Surgical Innovations plc said: "David has played an important role over the last 20 years in founding the Elemental business, as CEO of the Surgical Innovations team and as a Board member. I would like to thank David for his outstanding commitment to the business and look forward to his continued involvement as a Non-Executive Director and advisor going forward.

“We are delighted to welcome Alex on board, and we look forward to him leading the Surgical Innovations team. He has been instrumental in developing industry-leading products in his past roles and has a track record of delivery. Alex brings significant commercial and operational expertise to the business including successful new product launches. We believe Alex has the right skillset to execute on our future plans and deliver long term value to shareholders."

David Marsh commented: "I am pleased to be able to transition from an executive to a Non-Executive role with Surgical Innovations. I am incredibly proud of what we have achieved and remain confident in the opportunities the business has ahead of it.  I look forward to being able to support Alex and to continue to contribute to the business as a Non-Executive Director."

Alex Warnock, incoming Chief Executive Officer commented: "I am excited to be joining Surgical Innovations Group. The business has significant potential and a broad range of minimally invasive surgical products with exciting growth opportunities in new markets. I'm looking forward to working with Roy, the rest of the Board, and the Surgical Innovations team to deliver on the opportunity ahead of us."  

The following information is disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies:

Alex Warnock (aged 61) is currently, or has during the past five years, been a director of the following companies

Current directorships or partnerships	Previous directorships or partnerships
None	Galton Tradeco Limited Galton Bidco Limited Galton Topco Limited Foster & Freeman Limited Galton Midco Limited

Save as set out in this announcement there are no further details to be disclosed in accordance with Rule 17 and Schedule Two Paragraph (g) of the AIM Rule for Companies.

For further information please contact:

Surgical Innovations Group plc		www sigroupplc com
Roy Davis, Chair David Marsh, CEO		Tel: [phone]
David Anderson, CFO
Singer Capital Markets (Nominated Adviser & Broker)			Tel: [phone]
Alex Bond / Peter Steel / Anastassiya Eley
Walbrook PR (Financial PR & Investor Relations)	Tel: [phone] or [e-mail]
Paul McManus / Alice Woodings		Mob: [phone]

About Surgical Innovations Group plc

The Group specialises in the design, manufacture, sale and distribution of innovative, high quality medical products, primarily for use in minimally invasive surgery. Our product and business development is guided and supported by a key group of nationally and internationally renowned surgeons across the spectrum of minimally invasive surgical activity.

We design and manufacture and source our branded port access systems, surgical instruments and retraction devices which are sold directly in the UK home market through our subsidiary, Elemental Healthcare, and exported widely through a global network of trusted distribution partners. Many of our products in this field are based on a "resposable" concept, in which the products are part reusable, part disposable, offering a high quality and environmentally responsible solution at a cost that is competitive against fully disposable alternatives.

Elemental also has exclusive UK distribution for a select group of specialist products employed in laparoscopy, bariatric and metabolic surgery, hernia repair and breast reconstruction.

In addition, we design and develop medical devices for carefully selected OEM partners and have also collaborated with a major UK industrial partner to provide precision engineering solutions to complex problems outside the medical arena.

We aim for our brands to be recognised and respected by healthcare professionals in all major geographical markets in which we operate and provide by development, partnership or acquisition a broad portfolio of cost effective, procedure specific surgical instruments and implantable devices that offer reliable solutions to genuine clinical needs, the Company’s Resposable portfolio enables healthcare providers to reduce both plastic waste and their CO2 footprint as they strive for net zero.

Further information

Further details of the Group's businesses and products are available on the following websites:

www.sigroupplc.com

www.surginno.com

www.elementalhealthcare.co.uk

To receive regular updates by email, please contact [e-mail]

 

END